Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IntraBiotics initiates phase II clinical trial for oral mucositis treatment

Nov. 17, 1998

SU-101 may be indicated for combination therapy of prostate cancer

Nov. 17, 1998

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Nov. 16, 1998

Oxigene initiates phase I clinical trials of combretastatin

Nov. 16, 1998

Prolifix and Chugai extend research collaboration

Nov. 16, 1998

Leo's oral vitamin D analogue induces regression, inhibits tumor growth in hepatocellular carcinoma

Nov. 13, 1998

Taiho isolates new antiproliferative agent from Nocardiopsis strain

Nov. 13, 1998

Xenova to begin phase II efficacy trials of XR-5000

Nov. 13, 1998

OSI Pharmaceuticals updates anticancer programs

Nov. 13, 1998

Favorable phase III trial results presented for Evacet at ESMO; company prepares NDA

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...